Dr. Tong is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
sfstroke. com
San Francisco, CA 94131
Summary
- Dr. David Tong is a neurologist in San Francisco, CA and is affiliated with multiple hospitals in the area, including California Pacific Medical Center, Novato Community Hospital, Sutter Lakeside Hospital, Sutter Santa Rosa Regional Hospital, California Pacific Medical Center-St. Luke's Campus, Mills-Peninsula Health Services, and Sutter Medical Center, Sacramento. He received his medical degree from Baylor College of Medicine and has been in practice nearly 30 years. He specializes in vascular neurology and neurocritical care and is experienced in cerebrovascular disease, telemedicine, advanced neuroimaging, neuroimaging, and neurocritical care.
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Vascular Neurology, 1993 - 1995
- Stanford Health Care-Sponsored Stanford UniversityResidency, Neurology, 1990 - 1993
- Kaiser Permanente Northern California (Oakland)Internship, Internal Medicine, 1989 - 1990
- Baylor College of MedicineClass of 1989
Certifications & Licensure
- CA State Medical License 1990 - 2026
- American Board of Psychiatry and Neurology Neurology
- United council medical specialtiesNeurocritical Care
- United council medical specialtiesNeurocritical Care
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
Publications & Presentations
PubMed
- 23 citationsMDM2, MDMX, and p73 regulate cell-cycle progression in the absence of wild-type p53.Alyssa M. Klein, Lynn Biderman, David Tong, Bita Alaghebandan, Sakina A. Plumber
Proceedings of the National Academy of Sciences of the United States of America. 2021-11-02 - 321 citationsEfficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial.Michael D. Hill, Mayank Goyal, Bijoy K Menon, Raul G. Nogueira, Ryan A McTaggart
Lancet. 2020-03-14 - 3 citationsICU Interventions in Ischemic Stroke Patients Treated Using Liberalized IV-tPA Criteria.Nick M Murray, Michael Ke, Alan Yee, Charlene Chen, Christine Wong
Journal of Stroke and Cerebrovascular Diseases. 2019-07-03
Press Mentions
- Coronavirus: Bay Area ERs Are Eerily Empty and Worried You’re Too Afraid to VisitApril 22nd, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: